Biogen Inc was downgraded by Piper Sandler due to challenges faced during a transition period. The brokerage lowered the price target, expressing concerns over revenue mix, Alzheimer's franchise, and headwinds in the multiple sclerosis portfolio. Tesla's stock dropped 4% after missing delivery expectations.